Chemdoodle license or equal

The U.S. Food and Drug Administration (FDA) Office of Acquisition and Grant Services is seeking quotations for a ChemDoodle Advanced Software Suite Annual Site License Renewal with Maintenance and Technical Support through Request for Quote (RFQ) 75F40126Q00042. The procurement requires a one-year site license capable of supporting over 1,100 FDA users, including chemists and informatics staff, with the software compatible across Windows, Mac OS, and Linux operating systems. Key technical requirements include chemical structure drawing capabilities, export functionality in multiple formats (molfile, SMILES, InChI, SD file, CDX), bulk viewing and import capabilities, IUPAC naming features, calculations, references, and 3D conformer generation. The government will make award decisions using Lowest Price Technically Acceptable (LPTA) criteria without clarification or discussions, prioritizing the lowest-priced quotation that meets all technical specifications. Quotations are due electronically by January 30, 2026, at 5:00 p.m. EST, with questions required to be submitted by January 29, 2026.

This procurement is designated as a Total Small Business Set-Aside with NAICS code 813920 and a small business size standard of $25.5 million or $14 million in revenue depending on classification. iChemLabs, through authorized reseller BMT Micro, Inc., is identified as the known source for this software and associated maintenance and technical support, though other authorized resellers or servicing agents may quote. The contract is structured as firm-fixed price with a 12-month period of performance running from January 21, 2026, to January 20, 2027, and specific budget information is not disclosed in the solicitation materials. Eligible quoters must be either the Original Equipment Manufacturer (OEM) or an authorized reseller/servicing agent of the software manufacturer. All deliverables, including software licenses, licensing keys, user manuals in digital format, and technical support access including product releases and updates, must be delivered to the FDA at its North Bethesda, Maryland facility within ten business days after contract award.